Acer Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2021 to Q3 2023
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Acer Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q3 2023.
- Acer Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 24.5M shares, a 52.1% increase year-over-year.
- Acer Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 15.8M shares, a 10.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)